FLT3 inhibition in acute myeloid leukaemia
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference10 articles.
1. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis;Thiede;Blood,2002
2. Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD;Takahashi;Br J Haematol,2013
3. Secondary mutations as mediators of resistance to targeted therapy in leukemia;Daver;Blood,2015
4. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study;Perl;Lancet Oncol,2017
5. FXa variants advance toward a therapy for bleeding
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment;Cell Reports Medicine;2023-11
2. Design, synthesis and biological evaluation of 2-aminopyrimidine derivatives as potent FLT3 inhibitors;Bioorganic & Medicinal Chemistry Letters;2023-11
3. Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells;Molecules;2023-07-06
4. TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis;Frontiers in Immunology;2021-03-12
5. Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia;Haematologica;2021-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3